The President of the Federal Republic of Nigeria, Muhammadu Buhari has approved the appointment of Dr Obi Peter Adigwe, as the new Director General of the National Institute for Pharmaceutical Research and Development (NIPRD), Abuja.
The appointment, which was announced on Monday, revealed that Adigwe had the highest score in a comprehensive interview process, which had in attendance, some of the best candidates in Nigerian Pharmaceutical Research and Development.
Before his appointment as the DG NIPRD, he was the Executive Secretary of the Pharmaceutical Manufacturers Group (PMGMAN), where, according to reports he made significant contributions to the development and implementation of policy initiatives which made considerable impact on the Industry.
Adigwe, who has authored and co-authored several publications in peer review journals, pioneered Head of the Health Policy Research and Development (HPRD) Unit at the Nigerian National Assembly, where he formulated research and development strategies in Health Policy as well as developed innovative and contextual training, research and capacity building modules.
After graduating from the University of Jos, where he bagged his Bachelor of Pharmacy, Adigwe had obtained other post-graduate degrees from international institutions. He attended the University of Edinburgh, for his Master’s Degree in Global Health and Public Policy; also went to the University of Leeds, for his Doctor of Philosophy (Ph.D.) in Global Health and Public Policy.
However, Pharmanewsonline gathered that there are reactions to the appointment from some quarters, which are questioning the emergence of Adigwe amidst several ‘qualified’ candidates that applied for the position.